DB
SEM

Dmitry Balyasny’s Select Medical SEM Stock Holding History

Dmitry Balyasny’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-278,400
Closed -$2.25M – 1452
2020
Q1 		$2.25M Buy
+278,400
New +$3.31M 0.03% 598

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Dmitry Balyasny's SEM Position: Q2 2026 in Review

Dmitry Balyasny increased its Select Medical (SEM) stake by 79% in Q2 2026, buying an estimated $11.9M and bringing the position to 1,623,940 shares worth $26.8M. The position accounts for 0.03% of the portfolio, ranked #591.

Dmitry Balyasny first reported a position in SEM in Q3 2015 and has held it in 18 quarters since. 239 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Dmitry Balyasny held 1,623,940 shares of Select Medical worth $26.8M as of Q2 2026.
  • Dmitry Balyasny bought 719,203 Select Medical shares in Q2 2026, an estimated $11.9M.
  • Select Medical made up 0.03% of Dmitry Balyasny's portfolio in Q2 2026, its #591 holding.
  • Dmitry Balyasny first reported a position in Select Medical in Q3 2015 and has held it in 18 quarters since.
  • 239 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.